Company
Overview
Our Commitment
Core Values
Executive Leadership
Services
Discovery & Preclinical
Pharmacology Services
Drug Safety Assessment
General Toxicology
Safety Pharmacology
Genetic Toxicology
Early Clinical Research (Phase I – IIa)
Phase I-IIa
Bioequivalence Studies
Pharmacokinetics / Pharmacodynamics
Global Clinical Development (Phase II-IV)
Development and Regulatory Services
Feasibility Research
Investigator and Patient Recruitment
Project Management and Clinical Monitoring
Medical Affairs and Safety Management
Central Lab & Centralized Cardiac Services
Data Management
Biostatistics
Medical and Scientific Writing
Quality Assurance
Connecting your trials to global regions
Bioanalysis
Small Molecule Bioanalysis
Large Molecule Bioanalysis
Validated Assays
Global Central Lab
Global Services
Centralized Cardiac Services
ECG Devices
ECG Locations
Quality Assurance
Development & Regulatory Services
Drug Development
Biopharmaceutical Development
Regulatory Affairs
Program Management
Quality Assurance Services
Cardiac Safety Center of Excellence
Therapeutic Experience
List A-Z
List by Location
Locations
All Locations
Executive Offices
Discovery & Preclinical
Early Clinical Research
Global Clinical Development (Phase II-IV)
Bioanalysis
Global Central Lab
Scientific Library
Posters
Presentations
Podcasts
Webinars
Case Studies
White Papers
Events
News
News Releases
Media Coverage
Contact Us
Study Participation
Medical Investigators
Careers at MDS
Investors
MDS Pharma Services News
April 28, 2009
MDS Pharma Services Announces Collaboration with Compendia Bioscience, Inc. to Deliver Novel Solution for Oncology Drug Development
April 8, 2009
MDS Pharma Services Appoints Dr. Ping Li as Laboratory Director for Beijing Central Lab
March 11, 2009
MDS Pharma Services Scientist Named to List of ‘Notable People in R&D’ for 2009
February 12, 2009
MDS Pharma Services Scientist to Discuss Development of Biosimilar Monoclonal Antibodies at EGA Symposium
More news from MDS Inc.
Home
/
Scientific Library
/
Posters
Posters
Society of Toxicology 2009
Title
Authors(s)
Related Event
Date
Preview
Multiparametric Hepatotoxicity Screening in HepG2 Cells with Comparison in Primary Hepatocytes
K.F. Marcoe, Y. Ovechkina, R. Keyser, P. TB. Nguyen, C. O’Day
SOT
2009
Click here
Elucidation of cytokine storm: the effect of in-vitro antibody immobilization methods on cytokine secretion in a cell-based assay
J.A. Mulligan, R. Shively, and C.L. O’Day
SOT
2009
Click here
Posters Archive
Title
Author(s)
Related Event
Date
Preview
Request
M118, A Novel, Rationally Engineered Low Molecular Weight Heparin, with Potent Anti-XA AND Anti-IIA Activities
I. Fier, M. Abu-Rashid, G. Morelli, M. Richey, J. Roach, D. Goblot, S. Boudriau
ASCPT
2009
Managing Clinical Trial Approval (CTA) Aceptability to Support Phase I Clinical Studies in the United Kingdom
S. Roberts, F. McNeilly, R. Hunter and H.W. Scheer
ASCPT
2009
Randomized, Open-Label, Single-Dose, Two-Way Crossover Study of a Reformulated Levothyroxine Tablet Compared With the Commercial Tablet (Levoxyl®)
T. M. Grant, PhD, Y. Zhu, MS, C.M. Brandquist, PharmD, MS, N. S. Teuscher, PhD, M. J. Lamson, PhD
ASCPT
2009
Synergistic Effects of CD40L and Cytokines on Cytokine Production, Proliferation and Antibody Production
Rodney D. Shively, Jenny A. Mulligan, and Christine L. O’Day
Cytokines
2008
Assessment of Extract Cleanliness using different On-line Clean up Selectivities for a Turbulent flow Chromatography(TFC)
L. Neudert, S. Wood, P. Struwe
Montreux
2008
Evaluation and Comparision of the Matrix Factor in Various Mass Spectrometric Ionisation Modes for the Determination of Exemestane in Human Plasma
M. Erbs, S. Wood, M. Zaugg, P. Struwe
Montreux
2008
High Troughput LC-MS/MS Aanalysis of Free and Total Ezetimibe in Human Plasma
D.A. Raines, J. O. Rathe, D. D. Grafelman, K. M. Harris, A. M. Dzerk, C. J. Kafonek, C. J. Briscoe, C. E. Sheldon
AAPS
2008
A Highly Sensitive Method for the Quantification of Total Naloxone in Human Plasma (EDTA) Via LC-MS/MS
Ginny B. James, Jonathan O. Rathe, Daryl Grafelman, Curtis E. Sheldon, Chad J. Briscoe
AAPS
2008
Characterization of Kinase Inhibitors by In Vitro and Functional Cellular Assays
G. Castillo, J. Hnilo, S. Bounds, M. Gross, K. Yoshino and L. Martel
Drug Discovery & Development Therapeutics
2008
A sensitive, high-throughput method for the quantification of Theophylline in human plasma via solid phase purification and LC-MS/MS detection
Sarah K. Roby, Yousef J. Basir, Kirk E. Newland
56th ASMS Conference
2008
A New approach for highly sensitive quantitative LC-MS/MS analysis of N-Nitrosonornicotine
Richard Olsen, Veni Lapko and Kirk Newland
56th ASMS Conference
2008
An ultrasensitive LC-MS/MS method for the Quantification of 6ß-Naltrexol in human plasma using Peak Summing
Erica Nachi; Ginny James; Chris Kafonek; Curtis Sheldon; Chad J Briscoe
56th ASMS Conference
2008
A sensitive semi-automated method for quantification of trace Dexamethasone in human plasma by LC-MS/MS
Jonathan Rathe; Karl Linderholm; Dale Raines; Chris Kafonek; Curtis Sheldon; Chad J Briscoe
56th ASMS Conference
2008
Development of a high throughput method for the quantification of Cholecalciferol in human plasma
Lee Winchester; Anthony Podany; Corey Ohnmacht; Wei Sun; Chad Briscoe
56th ASMS Conference
2008
An Ultra-Sensitive method for LC-MS/MS analysis of 3-OH-BENZO[A]PYRENE in human urine
Veni Lapko, Rhida Nachi, Yosef Basir and Kirk Newland
56th ASMS Conference
2008
Lack of Drug-Drug Interactions with M118, a Novel, Rationally Engineered Low Molecular Weight Heparin
M. Abu-Rashid, S. Boudriau, G. Morelli, D. St-Fleur, D. Goblot, E. O’Neil, J. Roach and I. Fier
CPT
2008
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of M118, a Novel Rationally Engineered Low Molecular Weight Heparin
S. Boudriau, M. Abu-Rashid, G. Morelli, D. Rivard, M. Khyari1, E. O’Neil, J. Roach and I. Fier
CPT
2008
An LC-MS/MS method for the Quantification of Diazepam and N-Desmethyldiaezpam in Human Plasma (EDTA)
inny B. James, Jonathan O. Rathe, Curtis E. Sheldon, Chad J. Briscoe
Land o’Lakes
2008
Automatic Estimate Statement Creation
Lucius Reinbolt, Kalyani Kothapalli
Pharma SUG
2008
Lack of clinically significant effect of Bilastine on Ventricular Repolarisation: A Thorough QT Study
Sologuen, A MD; Valiente, R M; Allison, Mark J MD; Tyl, Benoît MD
EACCI
2008
<< First
|
< Prev
[Page
1
of
3
]
Next >
|
Last >>
© 2009 MDS Pharma Services |
Corporate Governance
|
Legal
|
Privacy
|
Site Map